Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Oct 19;12:692079. doi: 10.3389/fimmu.2021.692079

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2021 Ma, Jiang, Luo, Liao, Xu, Wang, Dong, Ji and Wang

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Ti-lncRNA signature and immunotherapy response. (A) Associations of the signature risk score with the expression of PDCD1 and CTLA4 and the expanded IGS score. (B) Sub-map analyses of the Ti-lncRNA signature in melanoma patients undergoing blockade therapy of PD-1 and CTLA4. (C) Kaplan–Meier survival curves of OS among four patient groups stratified by the Ti-lncRNA signature, PDCD1 and CTLA-4 expressions, and the expanded IGS scores. lncRNA, long non-coding RNA; Ti-lncRNA, tumor-infiltrating immune-related lncRNA; TCGA, The Cancer Genome Atlas; CAF, cancer-associated fibroblast; TAM, tumor-associated macrophage; IGS, immune gene signature; OS, overall survival.